What evidence supports parathyroidectomy for primary hyperparathyroidism in patients with normal serum calcium who have neurocognitive symptoms?

Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism with Neurocognitive Symptoms

Parathyroidectomy should be considered for patients with primary hyperparathyroidism who have neurocognitive symptoms, even when serum calcium is normal, as objective evidence demonstrates that these symptoms improve after surgery.

Evidence for Neurocognitive Effects in PHPT

The relationship between primary hyperparathyroidism and neurocognitive dysfunction is well-established, regardless of calcium levels:

• Neurocognitive impairment occurs frequently in PHPT patients, with preoperative dysfunction documented in 44% of patients using objective testing, which improved to 22% postoperatively—representing improvement in 53% of the cohort 1.

• Specific cognitive domains affected include executive function and processing speed, with impaired executive functioning present in 13% of patients preoperatively (decreasing to 2% postoperatively, P<0.01) and impaired cognitive processing speed in 26% preoperatively (decreasing to 6% postoperatively, P<0.01) 2.

• Sleep disturbances are common, affecting 44% of patients preoperatively and decreasing to 31% postoperatively (P<0.01) 2.

Critical Finding: Calcium Levels Do Not Correlate with Symptoms

The severity of hypercalcemia does not predict the presence or severity of neurocognitive symptoms:

• In a large study of 20,081 consecutive adults, patients with calcium 10.0-11.0 mg/dL had identical symptom profiles compared to those with calcium >11.0 mg/dL, including fatigue (72% in both groups), sleep disturbances (68% vs 65%), and bone pain (50% vs 48%) 3.

• This finding directly supports considering parathyroidectomy in normocalcemic patients with symptoms, as the traditional calcium threshold of >1 mg/dL above normal lacks evidence-based support for symptom correlation 3.

Normocalcemic PHPT as a Distinct Entity

Normocalcemic primary hyperparathyroidism (NHPT) represents an early stage of disease evolution 4, 5:

• NHPT patients demonstrate similar biochemical profiles to hypercalcemic PHPT except for serum calcium levels, with comparable bone turnover markers and PTH levels 5.

• NHPT patients may have worse bone disease, showing significantly lower BMD and T-scores at the one-third distal radius compared to hypercalcemic PHPT, despite similar prevalence of nephrolithiasis and clinical fractures 5.

Mechanism and Timing of Improvement

Postoperative improvements occur rapidly and are mediated by PTH reduction:

• Cognitive improvements are observable as early as 2 weeks after parathyroidectomy 1.

• Reduction in intact PTH (not just calcium normalization) correlates with decreased state anxiety, which in turn associates with improved visuospatial working memory 6.

• Improvements span multiple domains including depressive symptoms, anxiety symptoms, visuospatial memory, and verbal memory 6.

Clinical Application Algorithm

When to Consider Surgery in Normocalcemic PHPT:

1. Document persistent elevation of PTH with multiple measurements of both total and albumin-corrected calcium confirming normocalcemia 5.

2. Exclude secondary causes: Ensure adequate vitamin D levels (>20 ng/mL) and adequate dietary calcium intake (>1000 mg/day) to rule out secondary hyperparathyroidism 5.

3. Objectively assess neurocognitive function using validated tools such as:

   • Formal neuropsychological testing (Stroop tests, Rey Auditory Verbal Learning Test, Groton Maze Learning Test) 2, 6
   • Brief Sleep Disturbance Inventory for sleep assessment 2
   • Validated cognitive screening tools like BrainCheck 1

4. Evaluate for other target organ effects: bone density (particularly at distal radius), kidney stones, chronic kidney disease 5.

Important Caveats:

• Among patients not meeting NIH consensus criteria for surgery, 50% (4 of 8) had preoperative impairment of sleep or cognitive function, and 75% of these (3 of 4) showed improvement postoperatively 2.

• Quality of life improvements are more consistently demonstrated than pure cognitive changes across multiple validated instruments 7, 8.

• Successful localization is essential for minimally invasive parathyroidectomy, which offers shorter operating times, faster recovery, and decreased perioperative costs compared to bilateral neck exploration 4.

Strength of Evidence

The evidence supporting parathyroidectomy for neurocognitive symptoms in normocalcemic PHPT includes:

• Multiple prospective studies with formal neuropsychological testing demonstrating objective improvements 2, 6, 1.

• Large-scale data (>20,000 patients) showing calcium levels do not predict symptoms 3, which undermines the rationale for withholding surgery based solely on calcium thresholds.

• Guideline recognition that PHPT presents with neurocognitive disorders as a manifestation of target organ involvement 4.

The most recent high-quality evidence (2024) using objective cognitive assessment confirms that parathyroidectomy results in quantifiable cognitive improvement, with benefits appearing within 2 weeks of surgery 1.